Such cancers are mainly related to the interaction of p53 with its negative regulators, among these the E3-ligase MDM2, which ubiquitinates p53 and promotes its proteasomal degradation via the ubiquitin–proteasome system [17,18,19]. The gene discussed is MDM2; the disease is cancer.